ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy)

American Journal of Cardiology

Volumn 94, Issue 7, 2004, Pages 859-863

  Cura, Fernando A ^a   Roffi, Marco ^b   Pasca, Narcis ^c   Wolski, Katherine E ^c   Lincoff, A Michael ^c   Topol, Eric J ^c   Lauer, Michael S ^c  

^a INSTITUTO CARDIOVASCULAR DE BUENOS AIRES   (Argentina)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; RETEPLASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DRUG EFFICACY; ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HEART CONDUCTION SYSTEM; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PREDICTIVE VALUE OF TESTS; RECOMBINANT PROTEINS; SURVIVAL ANALYSIS; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 5344237360     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.06.018     Document Type: Article

References (16)

1. E.J. Topol Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial Lancet 357 2001 1905 1914
2. R. Schroder, R. Dissmann, T. Bruggemann, K. Wegscheider, T. Linderer, U. Tebbe, K.L. Neuhaus Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction J Am Coll Cardiol 24 1994 384 391
3. R. Schroder, K. Wegscheider, K. Schroder, R. Dissmann, W. Meyer-Sabellek Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial J Am Coll Cardiol 26 1995 1657 1664
4. D.B. Rubin Estimating causal effects from large data sets using propensity scores Ann Intern Med 127 1997 757 763
5. M.M. Joffe, P.R. Rosenbaum Invited commentary: propensity scores Am J Epidemiol 150 1999 327 333
6. A.M. Lincoff, E.J. Topol Illusion of reperfusion Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation 88 1993 1361 1374
7. L. Pilote, D.P. Miller, R.M. Califf, E.J. Topol Recurrent ischemia after thrombolysis for acute myocardial infarction Am Heart J 141 2001 559 565
8. E.M. Antman, R.P. Giugliano, C.M. Gibson, C.H. McCabe, P. Coussement, N.S. Kleiman, A. Vahanian, A.A. Adgey, I. Menown, H.J Rupprecht Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis In Myocardial Infarction (TIMI) 14 trial The TIMI 14 Investigators Circulation 99 1999 2720 2732
9. E.M. Antman, C.M. Gibson, J.A. de Lemos, R.P. Giugliano, C.H. McCabe, P. Coussement, I. Menown, C.A. Nienaber, T.C. Rehders, M.J Frey Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14 The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators Eur Heart J 21 2000 1944 1953
10. The SPEED Group (Strategies for the Patency Enhancement in the Emergency Department) Randomized trial of abciximab with and without low-dose reteplase for acute myocardial infarction Circulation 101 2000 2788 2794
11. B.S. Coller GPIIb/IIIa antagonists: pathophysiologic and therapeutic insights from studies of c7E3 Fab Thromb Haemost 78 1997 730 735
12. J.A. de Lemos ST-segment resolution as a marker of epicardial and myocardial reperfusion after thrombolysis: insights from the TIMI 14 and in TIME-II trials J Electrocardiol 33 2000 67 72
13. P.W. Armstrong, G.S. Wagner, S. Goodman, F. Van De Werf, C.B. Granger, L. Wallentin, Y. Fu ST segment resolution in the ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarction Eur Heart J 24 2003 1515 1522
14. G.M. Santoro, R. Valenti, P. Buonamici, L. Bolognese, G. Cerisano, G. Moschi, M. Trapani, D. Antoniucci, P.F. Fazzini Relation between ST-segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated with direct angioplasty Am J Cardiol 82 1998 932 937
15. J.A. de Lemos, E.M. Antman, R.P. Giugliano, C.H. McCabe, S.A. Murphy, F. Van de Werf, C.M. Gibson, E. Braunwald ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy Thrombolysis In Myocardial Infarction (TIMI) 14 investigators Am J Cardiol 85 2000 299 304
16. A.W. van 't Hof, A. Liem, M.J. de Boer, F. Zijlstra Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction Zwolle Myocardial Infarction Study Group Lancet 350 1997 615 619